Robert L. Sufit

Q: What Schools Are Affiliated With Robert L. Sufit

Robert L. Sufit is affiliated with the following schools: Northwestern University, University of Wisconsin–Madison, Johns Hopkins University, University of Pittsburgh

Robert L. Sufit's AcademicInfluence.com Rankings

Robert L. Sufit

Medical

#2155

World Rank

#2558

Historical Rank

Neurology

#328

World Rank

#421

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Robert L. Sufit Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Robert L. Sufit is a professor of neurology at Northwestern University's Feinberg School of Medicine in Chicago and the husband of Judge Diane Wood of the United States Court of Appeals for the Seventh Circuit. Dr. Sufit received his Bachelor of Arts and Master of Arts in chemistry from Johns Hopkins University. He studied medicine at the University of Virginia School of Medicine and completed a residency in neurology at the University of Pittsburgh. Dr. Sufit studies peripheral nervous system disorders. He currently directs the Lois Insolia ALS Clinic at Northwestern Memorial Hospital, where he treats patients diagnosed with ALS.

(See a Problem?)

Robert L. Sufit's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia (2011) (1071)
SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. (2011) (570)
Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review) (1999) (474)
FUS‐immunoreactive inclusions are a common feature in sporadic and non‐SOD1 familial amyotrophic lateral sclerosis (2010) (324)
Neuro-QOL (2012) (299)
Chronic compartment syndrome: Diagnosis, management, and outcomes (1985) (271)
An outbreak of eosinophilic meningitis caused by Angiostrongylus cantonensis in travelers returning from the Caribbean. (2002) (246)
Practice parameter: The care of the patient with amyotrophic lateral sclerosis (An evidence‐based review) (1999) (238)
Practice Parameter: The Care of the Patient with Amyotrophic Lateral Sclerosis (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology (1999) (229)
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III (2009) (207)
Asymptomatic Peripheral Arterial Disease Is Associated With More Adverse Lower Extremity Characteristics Than Intermittent Claudication (2008) (144)
Paraoxonase cluster polymorphisms are associated with sporadic ALS (2006) (135)
A multicenter study on the use of pulsed low-intensity direct current for healing chronic stage II and stage III decubitus ulcers. (1993) (123)
Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction (2003) (116)
Relationships between speech intelligibility and the slope of second-formant transitions in dysarthric subjects (1989) (107)
Quantitative description of the dysarthria in women with amyotrophic lateral sclerosis. (1992) (106)
Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1 (2013) (101)
The effect of pedaling frequency on glycogen depletion rates in type I and type II quadriceps muscle fibers during submaximal cycling exercise (2004) (100)
Impairment of speech intelligibility in men with amyotrophic lateral sclerosis. (1990) (94)
Speech deterioration in amyotrophic lateral sclerosis: a case study. (1991) (84)
Promoting excellence in end‐of‐life care in ALS (2005) (80)
Clinical trials of riluzole in patients with ALS (1996) (73)
Differential involvement of optineurin in amyotrophic lateral sclerosis with or without SOD1 mutations. (2011) (68)
Design of clinical therapeutic trials in amyotrophic lateral sclerosis. (1991) (66)
Effect of Low-Intensity vs High-Intensity Home-Based Walking Exercise on Walk Distance in Patients With Peripheral Artery Disease: The LITE Randomized Clinical Trial. (2021) (64)
Practice parameter for electrodiagnostic studies in ulnar neuropathy at the elbow: summary statement. American Association of Electrodiagnostic Medicine, American Academy of Neurology, American Academy of Physical Medicine and Rehabilitation. (1999) (62)
Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan. (2011) (58)
Acute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with methylprednisolone and vecuronium (1992) (57)
Effect of Granulocyte-Macrophage Colony-Stimulating Factor With or Without Supervised Exercise on Walking Performance in Patients With Peripheral Artery Disease: The PROPEL Randomized Clinical Trial (2017) (53)
Preferential denervation of the adductor muscles of the equine larynx. I: Muscle pathology. (1991) (52)
Effect of Resveratrol on Walking Performance in Older People With Peripheral Artery Disease: The RESTORE Randomized Clinical Trial (2017) (51)
Gastrostomy tube placement by endoscopy versus radiologic methods in patients with ALS: A retrospective study of complications and outcome (2013) (51)
Infantile olivopontocerebellar atrophy with spinal muscular atrophy (infantile OPCA + SMA). (1990) (50)
Lower extremity nerve function in patients with lower extremity ischemia. (2006) (46)
Physiologic and metabolic response to progressive and prolonged exercise in amyotrophic lateral sclerosis (1987) (45)
Prevalence and characteristics of pain in early and late stages of ALS (2013) (44)
NONMYELOABLATIVE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR REFRACTORY CIDP (2007) (43)
Respiratory improvement by muscle training in adult‐onset acid maltase deficiency (1983) (40)
Sudden monocular visual loss in pseudotumor cerebri. (1979) (40)
Lack of association of VEGF promoter polymorphisms with sporadic ALS (2006) (39)
Skeletal Muscle Pathology in Peripheral Artery Disease: A Brief Review. (2020) (36)
Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitis (2007) (35)
Intravenous thyrotropin-releasing hormone in patients with amyotrophic lateral sclerosis. Dose-response and randomized concurrent placebo-controlled pilot studies. (1987) (33)
Walking performance is positively correlated to calf muscle fiber size in peripheral artery disease subjects, but fibers show aberrant mitophagy: an observational study (2016) (33)
Suramin‐induced weakness from hypophosphatemia and mitochondrial myopathy. Association of suramin with mitochondrial toxicity in humans (1994) (31)
Respiratory Pattern and Tidal Volumes Differ for Pressure Support and Volume‐assured Pressure Support in Amyotrophic Lateral Sclerosis (2017) (31)
Lower Extremity Nerve Function, Calf Skeletal Muscle Characteristics, and Functional Performance in Peripheral Arterial Disease (2011) (28)
Cocoa to Improve Walking Performance in Older People With Peripheral Artery Disease (2020) (27)
DEFICIENCY OF MUSCLE CYTOCHROME C OXIDASE (CO) IN LEIGH'S DISEASE (1984) (26)
Visual evoked potential changes following renal transplantation. (1987) (26)
Open label study to assess the safety of VM202 in subjects with amyotrophic lateral sclerosis (2017) (26)
Clinicopathologic report of ocular involvement in ALS patients with C9orf72 mutation (2014) (24)
Vitamin D status, functional decline, and mortality in peripheral artery disease (2014) (24)
Peripheral artery disease, calf skeletal muscle mitochondrial DNA copy number, and functional performance (2018) (23)
Prolonged Compound Muscle Action Potential Duration in Critical Illness Myopathy: Report of Nine Cases (2004) (23)
Comparing 6-minute walk versus treadmill walking distance as outcomes in randomized trials of peripheral artery disease. (2019) (22)
Drug induced polymyositis secondary to leuprolide acetate (Lupron) therapy for prostate carcinoma. (1991) (22)
Clinical spectrum of fascial inflammation (1982) (21)
Hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyradiculoneuropathy (2020) (21)
MEANINGFUL CHANGE IN SIX-MINUTE WALK IN PEOPLE WITH PERIPHERAL ARTERY DISEASE. (2020) (20)
A modification of the modified barium swallow (1987) (18)
Symptomatic treatment of ALS (1997) (18)
Intermittent negative pressure ventilation in the treatment of respiratory failure in progressive neuromuscular disease (1987) (17)
Correlations of Calf Muscle Macrophage Content With Muscle Properties and Walking Performance in Peripheral Artery Disease (2020) (15)
Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS (2007) (15)
Randomized parallel placebo controlled pilot study of intravenous trh administration in amyotrophic lateral sclerosis patients increased strength and functional ability (1985) (12)
Distal acquired demyelinating symmetric neuropathy after vaccination. (2013) (11)
Associations of Peripheral Artery Disease With Calf Skeletal Muscle Mitochondrial DNA Heteroplasmy (2020) (11)
Compression of the brachial plexus during right lobe liver donation as a cause of brachial plexus injury: A case report (2005) (10)
ALS standard of care consensus (1997) (10)
Ketogenic effects of carnitine in patients with muscular dystrophy and cytochrome oxidase deficiency. (1988) (10)
Clinical Characteristics and Response to Supervised Exercise Therapy in People with Lower Extremity Peripheral Artery Disease. (2020) (10)
New approaches to the treatment of ALS (1997) (10)
American Academy of Neurology evidence-based review): Report of the Quality Standards Subcommittee of the Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an (2006) (9)
Doxacurium and Mivacurium Do Not Trigger Malignant Hyperthermia in Susceptible Swine (1990) (9)
Nifedipine relieves exercise‐exacerbated myalgias (1984) (9)
Reversible demyelinating neuropathy associated with renal cell carcinoma (2011) (8)
Degenerative Motor, Sensory, and Autonomic Disorders (2007) (8)
Isokinetic assessment in ALS. (1987) (8)
Walking Exercise Therapy Effects on Lower Extremity Skeletal Muscle in Peripheral Artery Disease. (2021) (8)
Decreased conduction velocity and pseudomyotonia in hexachlorobenzene-fed rats. (1986) (7)
Motor Neuron Disease (1990) (7)
Associations of Weight Change With Changes in Calf Muscle Characteristics and Functional Decline in Peripheral Artery Disease (2019) (6)
PULMONARY EFFECTS OF THYROTROPIN-RELEASING HORMONE IN AMYOTROPHIC LATERAL SCLEROSIS (1984) (6)
Thyrotropin releasing hormone uptake into serum and cerebrospinal fluid following intravenous or subcutaneous administration. (1988) (6)
Drug-induced peripheral neuropathy in a patient with psoriatic arthritis. (1987) (5)
Issues in clinical trial design I (1996) (5)
Intravenous thyrotropin releasing hormone in amyotrophic lateral sclerosis: autonomic effects. (1987) (3)
Perceived Versus Objective Change in Walking Ability in Peripheral Artery Disease: Results from 3 Randomized Clinical Trials of Exercise Therapy (2021) (3)
Amyotrophic lateral sclerosis and sarcoidosis (2009) (3)
Glycemic control and peripheral nerve conduction in children and young adults after 5-6 mo of IDDM. Wisconsin Diabetes Registry. (1992) (3)
Oculomotor involvement in myotonic dystrophy type 2 (2008) (3)
Increased Fiber Density after Subcutaneous TRH in Amyotrophic Lateral Sclerosis (ALS) Patients (1989) (3)
Mitochondrial DNA damage in calf skeletal muscle and walking performance in people with peripheral artery disease. (2020) (2)
Evaluation of the upper esophageal sphincter using simultaneous pressure measurements with a sleeve device and videofluoroscopy (1986) (2)
Guidelines for establishing a quality assurance program in an electrodiagnostic laboratory. (1999) (2)
Associations of Poly (ADP-Ribose) Polymerase1 abundance in calf skeletal muscle with walking performance in peripheral artery disease (2020) (2)
Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease: The TELEX Randomized Clinical Trial. (2022) (2)
Improved methodology for measuring timing and pressure of tongue-hard palate apposition in the initiation of swallowing. (2004) (2)
Sustained physical activity in peripheral artery disease: Associations with disease severity, functional performance, health-related quality of life, and subsequent serious adverse events in the LITE randomized clinical trial (2021) (1)
Gastrostomy Tube Placement by Endoscopy Versus Radiologic Methods in Patients with ALS: A Retrospective Review of Complications and Outcome (P01.101) (2012) (1)
Oxygen desaturation during swallowing (1993) (1)
CREUTZFELDT JAKOB DISEASE (CJD) WITH PRION PROTEIN GENE (PRNP) V2101 MUTATION (1999) (1)
A Longitudinal Study of Diffusion Tensor Imaging in ALS Patients (S36.004) (2013) (0)
UBQLN2 Mutations in ALS and ALS/Dementia: A Genetic, Functional and Histopathological Analysis (S05.006) (2012) (0)
Thyrotropin releasing hormone uptake into serum and cerebrospinal fluid following intravenous or subcutaneous administration. (1988) (0)
Dysregulated Genes, MicroRNAs, Biological Pathways, and Gastrocnemius Muscle Fiber Types Associated With Progression of Peripheral Artery Disease: A Preliminary Analysis (2022) (0)
A treatment model for ALS (1999) (0)
COMPARING SIX-MINUTE WALK VS. TREADMILL WALKING DISTANCE AS OUTCOMES IN RANDOMIZED TRIALS OF PERIPHERAL ARTERY DISEASE (2020) (0)
Abstract 13797: Effects of Resveratrol Supplementation on Walking Performance in Peripheral Artery Disease: A Randomized Clinical Trial (2016) (0)
G.P.13.04 In-frame deletion of the entire dystrophin rod domain prevents compensation by utrophin and causes an unusually severe muscular dystrophy (2009) (0)
The impact of the approval of riluzole (1996) (0)
Poster 78: Diagnostic Criteria for Stiff-Person Syndrome: A Case Report (2005) (0)
Reversibility of electrophysiologic abnormalities in diabetic renal failure (1986) (0)
Mitochondrial Complex Abundance, Mitophagy Proteins, and Physical Performance in People With and Without Peripheral Artery Disease. (2023) (0)
Walking performance is positively correlated to calf muscle fiber size in peripheral artery disease subjects, but fibers show aberrant mitophagy: an observational study (2016) (0)
Unusually severe muscular dystrophy upon in-frame deletion of the dystrophin rod domain and lack of compensation by membrane-localized utrophin. (2023) (0)
Abstract 17020: Exercise With or Without Weight Loss and Functional Decline in Overweight or Obese Adults With Peripheral Artery Disease (2018) (0)
BW A938U DOES NOT TRIGGER MALIGNANT HYPERTHERMIA IN SUSCEPTIBLE SWINE (1987) (0)
Zinc Metabolism in Amyotrophic Lateral Sclerosis (ALS): Increased Cerebrospinal Fluid Zinc Following Intravenous Ethylenediamine Tetra-acetic Acid (EDTA) or Thyrotropin Releasing Hormone (TRH) (1987) (0)
THE EFFECTS ON PEDAL FREQUENCY ON MUSCLE FIBER TYPE GLYCOGEN DEPLETION PATTERNS: 404 (1980) (0)
Erratum to: Walking performance is positively correlated to calf muscle fiber size in peripheral artery disease subjects, but fibers show aberrant mitophagy: an observational study (2017) (0)
Care of the Patient with ALS Page 3 (2003) (0)
Cigarette smoking and mitochondrial dysfunction in peripheral artery disease (2022) (0)
Erratum to: Walking performance is positively correlated to calf muscle fiber size in peripheral artery disease subjects, but fibers show aberrant mitophagy: an observational study (2017) (0)
Increased Loss of 180 Degree/Second Isokinetic Torque Early in the Course of Amyotrophic Lateral Sclerosis (ALS): Correlation with Stepping and Walking Velocity on Functional Testing (1987) (0)
Effects of Walking Exercise at a Pace With Versus Without Ischemic Leg Symptoms on Functional Performance Measures in People With Lower Extremity Peripheral Artery Disease: The LITE Randomized Clinical Trial (2022) (0)
Resting Energy Expenditure in Patients with Amyotrophic Lateral Sclerosis (2010) (0)

This paper list is powered by the following services:

Other Resources About Robert L. Sufit

en.wikipedia.org

What Schools Are Affiliated With Robert L. Sufit?

Robert L. Sufit is affiliated with the following schools: